Invention Grant
- Patent Title: Analysis of ubiquitinated polypeptides
-
Application No.: US16508991Application Date: 2019-07-11
-
Publication No.: US11352418B2Publication Date: 2022-06-07
- Inventor: Michael J. Comb , John Edward Rush, II , Jing Li , Ailan Guo
- Applicant: Cell Signaling Technology, Inc.
- Applicant Address: US MA Danvers
- Assignee: Cell Signaling Technology, Inc.
- Current Assignee: Cell Signaling Technology, Inc.
- Current Assignee Address: US MA Danvers
- Agency: DLA Piper LLP US
- Main IPC: C07K16/18
- IPC: C07K16/18

Abstract:
The disclosure relates to antibody reagents that specifically bind to peptides carrying a ubiquitin remnant from a digested or chemically treated biological sample. The reagents allow the technician to identify ubiquitinated polypeptides as well as the sites of ubiquitination on them. The reagents are preferably employed in proteomic analysis using mass spectrometry. The antibody reagents specifically bind to the remnant of ubiquitin (i.e., a diglycine modified epsilon amine of lysine) left on a peptide which as been generated by digesting or chemically treating ubiquitinated proteins. The inventive antibody reagents' affinity to the ubiquitin remnant does not depend on the remaining amino acid sequences flanking the modified (i.e., ubiquitinated) lysine, i.e., they are context independent.
Information query